Research Site — Kettering, Ohio

Research Site is a clinical research site located in Kettering, Ohio, United States 45429.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site has participated in 28 clinical trials.

Therapeutic areas: Cost Sharing, Acute Coronary Syndrome, Diabetes Mellitus, Type 2, Hypertriglyceridemia.

Sponsors: AstraZeneca, Amgen, Pearl Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kettering

Browse all research sites in Ohio · View every site in Kettering

• Charles F. Kettering Memorial Hospital
• Kettering Medical Center Network, Kettering Hospital
• Kettering Medical Center
• Greater Dayton Cancer Center
• CCOP - Dayton
• First Dayton Cancer Care
• Wells Institute for Health Awareness
• GSK Investigational Site
• Novo Nordisk Investigational Site
• Pfizer Investigational Site
• Kettering Health

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 28 clinical trials on record. Their work covers Cost Sharing, Acute Coronary Syndrome, Diabetes Mellitus, Type 2, Hypertriglyceridemia.

Is Research Site accredited by Crixeo Clinical Trials?

Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.